Michael Gordon Joyce
27Patents
5h-index
57Co-inventors
68Inventor score
Filing activity: Mar 12, 2014 → Feb 13, 2024
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10017543B2 | Prefusion RSV F proteins and their use | Chemistry; Metallurgy | 21 | Active |
| US10960070B2 | Prefusion coronavirus spike proteins and their use | Chemistry; Metallurgy | 15 | Active |
| US9738689B2 | Prefusion RSV F proteins and their use | Chemistry; Metallurgy | 14 | Active |
| US10301377B2 | Middle east respiratory syndrome coronavirus immunogens, antibodies, and their use | Physics | 11 | Active |
| US10961283B2 | Self-assembling insect ferritin nanoparticles for display of co-assembled trimeric antigens | Chemistry; Metallurgy | 6 | Active |
| US10400015B2 | Recombinant HIV-1 envelope proteins and their use | Physics | 3 | Active |
| US11459360B2 | Recombinant HIV-1 envelope proteins and their use | Physics | 2 | Active |
| US10420834B2 | Recombinant metapneumovirus F proteins and their use | Chemistry; Metallurgy | 2 | Active |
| US11130785B2 | Prefusion RSV F proteins and their use | Chemistry; Metallurgy | 1 | Active |
| US11939356B2 | Self-assembling insect ferritin nanoparticles | Chemistry; Metallurgy | 1 | Active |
| US11174292B2 | Substitutions-modified prefusion RSV F proteins and their use | Chemistry; Metallurgy | 1 | Active |
| US11878998B2 | Prefusion RSV F proteins and their use | Chemistry; Metallurgy | 1 | Active |
| US10759846B2 | Middle east respiratory syndrome coronavirus immunogens, antibodies, and their use | Physics | 0 | Active |
| US12275758B2 | Prefusion RSV F proteins and their use | Chemistry; Metallurgy | 0 | Active |
| US11963959B2 | Inhibitors for coronavirus | Chemistry; Metallurgy | 0 | Active |
| US11027007B2 | Recombinant metapneumovirus F proteins and their use | Chemistry; Metallurgy | 0 | Active |
| US11926656B2 | Antibodies and methods for the diagnosis and treatment of Epstein Barr Virus infection | Chemistry; Metallurgy | 0 | Active |
| US12145968B2 | Recombinant HIV-1 envelope proteins and their use | Physics | 0 | Active |
| US12084489B2 | Antibodies and methods for the diagnosis, prevention, and treatment of Epstein Barr virus infection | Physics | 0 | Active |
| US10858400B2 | Prefusion RSV F proteins and their use | Chemistry; Metallurgy | 0 | Active |
| US11865111B2 | Antiviral drugs targeting the N-terminal domain (NTD) of the coronavirus spike receptor binding domain (RBD) | Chemistry; Metallurgy | 0 | Active |
| US12233124B2 | Recombinant metapneumovirus f proteins and their use | Chemistry; Metallurgy | 0 | Active |
| US11236151B2 | Antibodies and methods for the diagnosis and treatment of Epstein Barr virus infection | Chemistry; Metallurgy | 0 | Active |
| US11786591B2 | Recombinant metapneumovirus F proteins and their use | Chemistry; Metallurgy | 0 | Active |
| US11964010B2 | Prefusion coronavirus spike proteins and their use | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.